News & Updates

Thicker macula tied to better vision

21 Apr 2020 by

In healthy eyes, a thicker macula and ganglion cell-inner plexiform layer (GCIPL) is associated with better visual functioning, according to a recent Singapore study.

Thicker macula tied to better vision

21 Apr 2020

APTITUDE hints at tocilizumab efficacy for JIA-associated uveitis

20 Apr 2020 by

Children with anti-TNF* refractory juvenile idiopathic arthritis (JIA)-associated uveitis did not respond well to the interleukin(IL)-6 receptor inhibitor tocilizumab, the phase II APTITUDE trial has shown. However, in the absence of alternatives, tocilizumab might still be a valuable adjunctive therapeutic option for this condition.

APTITUDE hints at tocilizumab efficacy for JIA-associated uveitis

20 Apr 2020

Two phase III trials shine spotlight on brolucizumab for nAMD

16 Apr 2020 by

The HAWK/HARRIER* trials reveal favourable outcomes with the anti-VEGF**-A brolucizumab – showing noninferiority to fixed-dose aflibercept in improving visual function, a sustained effect, and a favourable safety profile – for the treatment of neovascular age-related macular degeneration (nAMD).

Two phase III trials shine spotlight on brolucizumab for nAMD

16 Apr 2020

Teprotumumab casts hope for thyroid eye disease

09 Apr 2020 by

The human monoclonal anti-IGF-1R* antibody teprotumumab was effective in reducing proptosis or eye bulging in patients with the rare thyroid eye disease (TED) regardless of age, gender, and/or smoking status, according to pooled data presented at ENDO 2020.

Teprotumumab casts hope for thyroid eye disease

09 Apr 2020

COVID-19 unlikely to be transmitted through tears

02 Apr 2020 by

The transmission of the coronavirus disease 2019 (COVID-19) through tears appears to be unlikely, according to a Singapore study.

COVID-19 unlikely to be transmitted through tears

02 Apr 2020

Ophthalmologists must adopt Infection control measures during COVID-19 outbreak

01 Apr 2020

Ophthalmologists are advised to cooperate with local infection control teams in the implementation of infection control measures that are appropriate for their clinical settings in order to minimize the transmission of coronavirus disease 2019 (COVID-19), suggests a Hong Kong study.

Ophthalmologists must adopt Infection control measures during COVID-19 outbreak

01 Apr 2020

$Forward fixation of IOL causes myopic refractive errors after phacovitrectomy with gas tamponade$

Forward fixation of IOL causes myopic refractive errors after phacovitrectomy with gas tamponade

30 Mar 2020

Myopic refractive errors result from forward fixation of the intraocular lens (IOL) even when gas has disappeared in eyes undergoing phacovitrectomy with gas tamponade, a recent study has shown.

Forward fixation of IOL causes myopic refractive errors after phacovitrectomy with gas tamponade

30 Mar 2020

Bimatoprost-brimonidine-timolol eye drops effectively lower IOP in POAG, OHT patients

30 Mar 2020 by

A triple fixed combination of bimatoprost 0.01%/brimonidine 0.15%/timolol 0.5% ophthalmic solution provides superior intraocular pressure (IOP)-lowering effects compared with a dual fixed combination of brimonidine 0.2%/timolol 0.5% in patients with primary open-angle glaucoma (POAG) or ocular hypertension (OHT), according to the results of a phase III study.

Bimatoprost-brimonidine-timolol eye drops effectively lower IOP in POAG, OHT patients

30 Mar 2020

Repeat examination may be prudent after acute posterior vitreous detachment

29 Mar 2020

Incidences of newly detected retinal breaks and retinal detachments (RDs) are quite significant following acute posterior vitreous detachment (PVD), reveals a study, suggesting that repeat examination may be necessary in these patients.

Repeat examination may be prudent after acute posterior vitreous detachment

29 Mar 2020

Long-term hormone therapy may increase cataract risk in women with T2D

23 Mar 2020

Use of hormone therapy in the long term potentially carries a heightened risk of cataract in postmenopausal women with type 2 diabetes (T2D), a study reports.

Long-term hormone therapy may increase cataract risk in women with T2D

23 Mar 2020

News & Updates

Filter by Specialty:

Specialty:

Thicker macula tied to better vision

Thicker macula tied to better vision

APTITUDE hints at tocilizumab efficacy for JIA-associated uveitis

APTITUDE hints at tocilizumab efficacy for JIA-associated uveitis

Two phase III trials shine spotlight on brolucizumab for nAMD

Two phase III trials shine spotlight on brolucizumab for nAMD

Teprotumumab casts hope for thyroid eye disease

Teprotumumab casts hope for thyroid eye disease

COVID-19 unlikely to be transmitted through tears

COVID-19 unlikely to be transmitted through tears

Ophthalmologists must adopt Infection control measures during COVID-19 outbreak

Ophthalmologists must adopt Infection control measures during COVID-19 outbreak

Forward fixation of IOL causes myopic refractive errors after phacovitrectomy with gas tamponade

Forward fixation of IOL causes myopic refractive errors after phacovitrectomy with gas tamponade

Bimatoprost-brimonidine-timolol eye drops effectively lower IOP in POAG, OHT patients

Bimatoprost-brimonidine-timolol eye drops effectively lower IOP in POAG, OHT patients

Repeat examination may be prudent after acute posterior vitreous detachment

Repeat examination may be prudent after acute posterior vitreous detachment

Long-term hormone therapy may increase cataract risk in women with T2D

Long-term hormone therapy may increase cataract risk in women with T2D